Revolutionizing Healthcare – ReAlta Life Sciences Thrives as a Leading Tech Entrepreneur in Norfolk.
ReAlta Life Sciences, located in the Norfolk Innovation Corridor (NIC) has received FDA clearance for a Phase 2 Trial of RLS-0071 in patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AE-COPD). ReAlta is a bio-tech firm that is focused on treating life threatening acute inflammatory and rare diseases through its proprietary therapeutic platform that […]
Read More